{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:08:29Z","timestamp":1792786109086,"version":"4.5.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grant-in-Aid for JSPS Research"},{"name":"JSPS KAKENHI","award":["22J20047"],"award-info":[{"award-number":["22J20047"]}]},{"name":"JSPS KAKENHI","award":["22H03110"],"award-info":[{"award-number":["22H03110"]}]},{"name":"JSPS KAKENHI","award":["22KJ0995"],"award-info":[{"award-number":["22KJ0995"]}]},{"name":"Department of Functional Genomics and Immunological Diseases"},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objective of this study was to stratify patients with MCTD, based on their immunophenotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed the immunophenotype and transcriptome of 24 immune cell subsets [from patients with MCTD, SLE, idiopathic inflammatory myopathy (IIM) and SSc] from our functional genome database, ImmuNexUT (https:\/\/www.immunexut.org\/). MCTD patients were stratified by employing machine-learning models, including Random Forest, trained by immunophenotyping data from SLE, IIM and SSc patients. The transcriptomes were analysed with gene set variation analysis (GSVA), and the clinical features of the MCTD subgroups were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included 215 patients, including 22 patients with MCTD. Machine-learning models, constructed to classify SLE, IIM and SSc patients, based on immunophenotyping, were applied to MCTD patients, resulting in 16 patients being classified as having an SLEimmunophenotype and 6 as having a non-SLE immunophenotype. Among the MCTD patients, patients with the SLE immunophenotype had higher proportions of Th1 cells {2.85% [interquartile range (IQR) 1.54\u20133.91] vs 1.33% (IQR 0.99\u20131.74) P\u2009=\u20090.027} and plasmablasts [6.35% (IQR 4.17\u201317.49) vs 2.00% (IQR 1.20\u20132.80) P\u2009=\u20090.010]. Notably, the number of SLE-related symptoms was higher in patients with the SLE immunophenotype [2.0 (IQR 1.0\u20132.0) vs 1.0 (IQR 1.0\u20131.0) P\u2009=\u20090.038]. Moreover, the GSVA scores of interferon-\u03b1 and -\u03b3 responses were significantly higher in patients with the SLE immunophenotype in central memory CD8+ T cells, while hedgehog signalling was higher in patients with the non-SLE immunophenotype, in five-cell subsets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study describes the stratification of MCTD patients, based on immunophenotyping, suggesting the presence of distinct immunological processes behind the clinical subtypes of MCTD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae158","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T15:19:16Z","timestamp":1710256756000},"page":"1409-1416","source":"Crossref","is-referenced-by-count":7,"title":["Machine learning\u2013driven immunophenotypic stratification of mixed connective tissue disease, corroborating the clinical heterogeneity"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9724-4911","authenticated-orcid":false,"given":"Shinji","family":"Izuka","sequence":"first","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5890-3606","authenticated-orcid":false,"given":"Toshihiko","family":"Komai","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Itamiya","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo,","place":["Japan"]},{"name":"Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineto","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo,","place":["Japan"]},{"name":"Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Nagafuchi","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo,","place":["Japan"]},{"name":"Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Shoda","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Matsuki","sequence":"additional","affiliation":[{"name":"Research Division, Chugai Pharmaceutical Co., Ltd , Yokohama, Kanagawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences , Yokohama, Kanagawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo,","place":["Japan"]},{"name":"Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Fujio","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"key":"2025030500181234200_keae158-B1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14397595.2019.1709944","article-title":"2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases","volume":"31","author":"Tanaka","year":"2021","journal-title":"Mod. Rheumatol"},{"key":"2025030500181234200_keae158-B2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/joim.13752","article-title":"Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: a multicenter retrospective cohort","volume":"295","author":"Chevalier","year":"2024","journal-title":"J Intern Med"},{"key":"2025030500181234200_keae158-B3","first-page":"33","volume-title":"Mixed connective tissue disease and anti-nuclear antibodies","author":"Alarcon-Segovia"},{"key":"2025030500181234200_keae158-B4","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1093\/rheumatology\/keac703","article-title":"Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program","volume":"62","author":"Hasan","year":"2023","journal-title":"Rheumatology"},{"key":"2025030500181234200_keae158-B5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/rheumatology\/kead341","article-title":"Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in Mixed connective tissue disease","volume":"63","author":"Todoroki","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2025030500181234200_keae158-B6","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1093\/rheumatology\/kead055","article-title":"In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre study","volume":"62","author":"Chaigne","year":"2023","journal-title":"Rheumatology"},{"key":"2025030500181234200_keae158-B7","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1093\/rheumatology\/keac165","article-title":"Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD","volume":"61","author":"Todoroki","year":"2022","journal-title":"Rheumatology"},{"key":"2025030500181234200_keae158-B8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025030500181234200_keae158-B9","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1002\/art.30466","article-title":"B cell biomarkers of rituximab responses in systemic lupus erythematosus","volume":"63","author":"Vital","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2025030500181234200_keae158-B10","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/art.40180","article-title":"Peripheral immunophenotyping identifies three subgroups based on T cell heterogeneity in lupus patients","volume":"69","author":"Kubo","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025030500181234200_keae158-B11","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.cell.2021.03.056","article-title":"Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases","volume":"184","author":"Ota","year":"2021","journal-title":"Cell"},{"key":"2025030500181234200_keae158-B12","first-page":"326","article-title":"Mixed connective tissue disease-enigma variations?","volume":"56","author":"Ciang","year":"2017","journal-title":"Rheumatology"},{"key":"2025030500181234200_keae158-B13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.berh.2016.03.002","article-title":"Mixed connective tissue disease","volume":"30","author":"Gunnarsson","year":"2016","journal-title":"Best Pract. Res. Clin. Rheumatol"},{"key":"2025030500181234200_keae158-B14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2169\/internalmedicine.38.386","article-title":"Mixed connective tissue disease","volume":"38","author":"Kasukawa","year":"1999","journal-title":"Intern. Med"},{"key":"2025030500181234200_keae158-B15","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025030500181234200_keae158-B16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2025030500181234200_keae158-B17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2025030500181234200_keae158-B18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"2025030500181234200_keae158-B19","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025030500181234200_keae158-B20","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2025030500181234200_keae158-B21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1067\/mjd.2002.120621","article-title":"Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?","volume":"46","author":"Sontheimer","year":"2002","journal-title":"J. Am. Acad. Dermatol"},{"key":"2025030500181234200_keae158-B22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/acr2.11521","article-title":"Transcriptome profiling of immune cell types in peripheral blood reveals common and specific pathways involved in the pathogenesis of myositis-specific antibody-positive inflammatory myopathies","volume":"5","author":"Sugimori","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"2025030500181234200_keae158-B23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nrrheum.2018.33","article-title":"Update on outcome assessment in myositis","volume":"14","author":"Rider","year":"2018","journal-title":"Nat. Rev. Rheumatol"},{"key":"2025030500181234200_keae158-B24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2025030500181234200_keae158-B25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"2025030500181234200_keae158-B26","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.3389\/fimmu.2019.01880","article-title":"Epigenome-wide comparative study reveals key differences between mixed connective tissue disease and related systemic autoimmune diseases","volume":"10","author":"Carnero-Montoro","year":"2019","journal-title":"Front. Immunol"},{"key":"2025030500181234200_keae158-B27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41584-023-00948-y","article-title":"Precision medicine in systemic lupus erythematosus","volume":"19","author":"Fasano","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2025030500181234200_keae158-B28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13075-021-02557-0","article-title":"The expansion of activated naive DNA autoreactive B cells and its association with disease activity in systemic lupus erythematosus patients","volume":"23","author":"Wangriatisak","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2025030500181234200_keae158-B29","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1084\/jem.20170580","article-title":"B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity","volume":"214","author":"Arkatkar","year":"2017","journal-title":"J Exp Med"},{"key":"2025030500181234200_keae158-B30","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1038\/s41467-021-22312-y","article-title":"Type I interferons affect the metabolic fitness of CD8+ T cells from patients with systemic lupus erythematosus","volume":"12","author":"Buang","year":"2021","journal-title":"Nat Commun"},{"key":"2025030500181234200_keae158-B31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/annrheumdis-2021-221464","article-title":"Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus","volume":"81","author":"Takeshima","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025030500181234200_keae158-B32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2025030500181234200_keae158-B33","doi-asserted-by":"crossref","first-page":"2259127","DOI":"10.1080\/08916934.2023.2259127","article-title":"The emerging role of the hedgehog signaling pathway in immunity response and autoimmune diseases","volume":"56","author":"Li","year":"2023","journal-title":"Autoimmunity"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae158\/57210158\/keae158.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1409\/57210158\/keae158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1409\/57210158\/keae158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:20:26Z","timestamp":1741116026000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/3\/1409\/7628320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,13]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae158","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,3,13]]}}}